United States: Prosecution Pointer 398 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

20 Oct 2023 0 shares 1 views

United States: Prosecution Pointer 398 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

Published 20 Oct 2023

At the USPTO, Patent Center is the next-generation system that incorporates all application submission types and file management functionality currently available in EFS-Web and Private PAIR...

Full Article

United States: Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq 31 Oct 2023

In Hope Medical Enterprises Inc., v. Fennec Pharmaceuticals Inc.,[i] the Board's Final Written Decision (FWD) found that Petitioner..

More coverage

United States: When To Consider Expert Testimony For Special Purpose Computer-Implemented Means-Plus-Function Claims - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq 23 Oct 2023

In Sisvel International S.A. v. Sierra Wireless, Inc., Nos. 2022-1493, 2022-1547 (Fed. Cir. Oct. 6, 2023), the Federal Circuit..

United States: Prosecution Pointer 398 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

United States: Prosecution Pointer 398 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

You might like

Related news coverage

United States: Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Advertisement

More coverage

United States: When To Consider Expert Testimony For Special Purpose Computer-Implemented Means-Plus-Function Claims - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP